Ligand News and Research

RSS
Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

28 Mar 2022
Study explores macrophage susceptibility to SARS-CoV-2 virions

Study explores macrophage susceptibility to SARS-CoV-2 virions

25 Mar 2022
Non-hormonal male contraceptive effectively prevents pregnancy in mice

Non-hormonal male contraceptive effectively prevents pregnancy in mice

24 Mar 2022
Study reveals new opportunities for using small molecule drugs to target KRAS mutants

Study reveals new opportunities for using small molecule drugs to target KRAS mutants

23 Mar 2022
CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

22 Mar 2022
The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

22 Mar 2022
Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

22 Mar 2022
Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

Glycogen synthase kinase-3 inhibitors found to attenuate COVID-19-associated cytokine storm

21 Mar 2022
Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

17 Mar 2022
Yale researchers uncover how to control the blood-brain barrier with a molecule

Yale researchers uncover how to control the blood-brain barrier with a molecule

16 Mar 2022
In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

16 Mar 2022
New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

16 Mar 2022
Acacetin shows potency against SARS-CoV-2 spike protein

Acacetin shows potency against SARS-CoV-2 spike protein

15 Mar 2022
Sustainable material-based biosensors for SARS-CoV-2 detection

Sustainable material-based biosensors for SARS-CoV-2 detection

15 Mar 2022
In silico screening of natural ACE2 inhibitors

In silico screening of natural ACE2 inhibitors

14 Mar 2022
Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

Further optimization of cysteine-reactive pyrazoline-based covalent inhibitors for the SARS-CoV-2 Mpro

11 Mar 2022
Study explores differentially expressed immune genes for COVID-19 patient stratification

Study explores differentially expressed immune genes for COVID-19 patient stratification

7 Mar 2022
Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

7 Mar 2022
Dual therapeutic potential of zapnometinib against COVID-19

Dual therapeutic potential of zapnometinib against COVID-19

2 Mar 2022
A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

1 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback